17-219694-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006987.4(RPH3AL):āc.656C>Gā(p.Ser219Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000992 in 1,613,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 29)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
RPH3AL
NM_006987.4 missense
NM_006987.4 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 3.77
Genes affected
RPH3AL (HGNC:10296): (rabphilin 3A like (without C2 domains)) The protein encoded by this gene plays a direct regulatory role in calcium-ion-dependent exocytosis in both endocrine and exocrine cells and plays a key role in insulin secretion by pancreatic cells. This gene is likely a tumor suppressor. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13857546).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPH3AL | NM_006987.4 | c.656C>G | p.Ser219Cys | missense_variant | 8/10 | ENST00000331302.12 | NP_008918.1 | |
RPH3AL | NM_001190411.2 | c.656C>G | p.Ser219Cys | missense_variant | 7/9 | NP_001177340.1 | ||
RPH3AL | NM_001190412.2 | c.569C>G | p.Ser190Cys | missense_variant | 7/9 | NP_001177341.1 | ||
RPH3AL | NM_001190413.2 | c.569C>G | p.Ser190Cys | missense_variant | 6/8 | NP_001177342.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPH3AL | ENST00000331302.12 | c.656C>G | p.Ser219Cys | missense_variant | 8/10 | 2 | NM_006987.4 | ENSP00000328977 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151748Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
3
AN:
151748
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248952Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134766
GnomAD3 exomes
AF:
AC:
9
AN:
248952
Hom.:
AF XY:
AC XY:
3
AN XY:
134766
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461728Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727150
GnomAD4 exome
AF:
AC:
13
AN:
1461728
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
727150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151748Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 74090
GnomAD4 genome
AF:
AC:
3
AN:
151748
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
74090
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.656C>G (p.S219C) alteration is located in exon 8 (coding exon 6) of the RPH3AL gene. This alteration results from a C to G substitution at nucleotide position 656, causing the serine (S) at amino acid position 219 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;.;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;.
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;.;N
REVEL
Benign
Sift
Pathogenic
.;.;.;D
Sift4G
Uncertain
D;D;D;D
Polyphen
B;B;B;B
Vest4
MVP
MPC
0.080
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at